Just for a bit of a recap on MK.
It was put out in 2016 and is interesting to compare to the current situation
https://www.nextbiotech.com.au/26m-capped-asx-stock-generating-millions-revenue-us-chinese-markets-next/
There is also this that makes interesting reading as well regarding the CAB103 developments. Quite a bit more recent.
https://bisouv.com/uncategorized/3239423/myocardial-ischemia-drugs-market-2021-is-booming-across-the-globe-by-share-size-growth-segments-and-forecast-to-2027-top-players-analysis-baxalta-incorporated-bayer-ag-cellmid-limited-cohbar/
Cheers
Pharma
Midkine and COVID 19, page-5
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable